Filing Flows › Alpha Teknova (TKNO) › Q1 2026
Alpha Teknova (TKNO) Q1 2026 earnings results (first quarter 2026)
10-Q filed May 7, 2026
Alpha Teknova (TKNO) reported revenue of $11.1M for the first quarter 2026 (Q1 2026), +13% from a year earlier and +11% from the quarter before. Operating margin was -38.8%, net loss $4.6M (41.1% of revenue).
Alpha Teknova, Q1 2026: revenue $11.1M (+13% year over year), operating margin -38.8%, net loss $4.6M, operating cash flow −$3.4M. The chart follows the revenue to costs, profit and cash.
| Q1 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $11.1M | +11% | +13% |
| Operating profit | −$4.3M | — | — |
| Net earnings | −$4.6M | — | — |
| Operating cash flow | −$3.4M | — | — |
What changed
Revenue was $11.1M in Q1 2026, up 13% year over year and up 11% from the previous quarter. Lab Essentials was the largest line at 76% of revenue. Clinical Solutions added $1.0M year over year (up 85%), 77% of the total change.
Gross margin was 34.2%, up 3.5 points from Q1 2025. Operating costs exceeded revenue by $4.3M, an operating margin of -38.8%. Operating expenses grew 1% against revenue growth of 13%. The fastest-growing cost line was Sales & marketing (+30%). The quarter ended with a net loss of $4.6M, narrower than the previous quarter's $4.8M loss.
Operating cash flow was −$3.4M. Non-cash charges added back $1.6M of depreciation and amortization and $695K of share-based compensation. Working capital and other items used $1.1M. Capital expenditures of $221K exceeded it, leaving free cash flow of −$3.6M.
Questions
What was Alpha Teknova's revenue in the first quarter 2026?
Alpha Teknova (TKNO) reported revenue of $11.1M for the first quarter 2026 (Q1 2026), +13% from a year earlier and +11% from the quarter before.
Was Alpha Teknova profitable in the first quarter 2026?
Operating loss was $4.3M (-38.8% of revenue) and net loss $4.6M.
Source: Alpha Teknova 10-Q on SEC EDGAR.